TAK-279
TAK-279-PsO-3005
Phase 3 small_molecule active
Quick answer
TAK-279 for Generalized Pustular Psoriasis is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Generalized Pustular Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active